Major Expansion Of Xceleron Inc In U.S.

6th September 2006 -- Xceleron, the pioneering service provider of ultra-sensitive analysis techniques for the acceleration of drug development, announces a new multimillion dollar investment to create its first pharmaceutical testing facilities in the U.S. The investment follows the successful establishment of its North American base in 2005 since when the company has experienced very significant demand for its services with substantial growth forecast from what is already estimated to be a $1bn market.